Conv. Plasma
Nigella Sativa

All povidone‑iodine studies
Meta analysis
study COVID-19 treatment researchPovidone-IodinePovidone-Iod.. (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Paxlovid Meta
Famotidine Meta Quercetin Meta
Favipiravir Meta Remdesivir Meta
Fluvoxamine Meta Thermotherapy Meta
Hydroxychlor.. Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial

Guenezan et al., JAMA Otolaryngol Head Neck Surg., doi:10.1001/jamaoto.2020.5490, NCT04371965
Feb 2021  
  Source   PDF   All Studies   Meta AnalysisMeta
Improvement in viral titer r.. 63% Improvement Relative Risk Povidone-Iodine  Guenezan et al.  EARLY TREATMENT  RCT Is early treatment with povidone-iodine beneficial for COVID-19? RCT 24 patients in France (September - October 2020) Improved viral load with povidone-iodine (not stat. sig., p=0.25) Guenezan et al., JAMA Otolaryngol Head.., Feb 2021 Favorspovidone-iodine Favorscontrol 0 0.5 1 1.5 2+
PVP-I for COVID-19
13th treatment shown to reduce risk in February 2021
*, now with p = 0.000000004 from 21 studies.
Lower risk for mortality, cases, and viral clearance.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,400+ studies for 79 treatments.
RCT of PCR+ patients with Ct<=20 with 12 treatment and 12 control patients, concluding that nasopharyngeal decolonization may reduce the carriage of infectious SARS-CoV-2 in adults with mild to moderate COVID-19. All patients but 1 had negative viral titer by day 3 (group not specified). There was no significant difference in viral RNA quantification over time. The mean relative difference in viral titers between baseline and day 1 was 75% [43%-95%] in the intervention group and 32% [10%-65%] in the control group. Thyroid dysfunction occurred in 42% of treated patients, with spontaneous resolution after the end of treatment. Patients in the treatment group were younger.
Targeted administration to the respiratory tract provides treatment directly to the typical source of initial SARS-CoV-2 infection and replication, and allows for rapid onset of action, higher local drug concentration, and reduced systemic side effects.
relative improvement in viral titer reduction between baseline and day 1, 63.2% better, RR 0.37, p = 0.25, treatment 12, control 12.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Guenezan et al., 4 Feb 2021, Randomized Controlled Trial, France, peer-reviewed, 7 authors, study period 1 September, 2020 - 23 October, 2020, trial NCT04371965 (history).
This PaperPovidone-Iod..All
Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19
Jeremy Guenezan, Magali Garcia, Deidre Strasters, Clément Jousselin, Nicolas Lévêque, Denis Frasca, MD Olivier Mimoz
JAMA Otolaryngology–Head & Neck Surgery, doi:10.1001/jamaoto.2020.5490
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is primarily transmitted person-to-person through the aerosolization of droplets containing contaminated nasopharyngeal secretions. 1 Povidone iodine (PI) solutions at concentrations as low as 0.5% rapidly inactivate SARS-CoV-2 in vitro with contact times as short as 15 seconds. 2 We investigated whether nasopharyngeal application of PI could reduce the viral load of patients with nonsevere coronavirus disease 2019 (COVID-19) symptoms.
Conflict of Interest Funding/Support: This project was supported by the University Hospital of Poitiers, France. This study did not benefit from financial support. Role of the Funder/Sponsor: University Hospital of Poitiers, France, had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Data Sharing Statement: See Supplement 2. Additional Contributions: We acknowledge Cynthia Bordage, RN, Bertrand Drugeon, MD, Amélie Mabille, MD, Nicolas Marjanovic, MD, Severine Mousse, MSc, Alexandre Rahoui, MD and Camille Raynaud, MD, who assisted in data collection and patient follow-up, Pierre Dupuis, PharmD, who performed the biochemical tests, and Jeffrey Arsham for editing assistance, all from the University hospital of Poitiers, France. There was no financial compensation for these contributions. OBSERVATION Adolescent Presentation of Nasal Chondromesenchymal Hamartoma: A Case Report and Literature Review Nasal chondromesenchymal hamartoma (NCMH) is a very rare benign tumor of the nasal cavity and paranasal sinuses that usually presents in infancy. These tumors may be expansile and locally destructive. The etiology has remained unclear, but it has been linked in the past to pleuropulmonary blastoma as
{ 'indexed': {'date-parts': [[2024, 3, 30]], 'date-time': '2024-03-30T12:27:24Z', 'timestamp': 1711801644140}, 'reference-count': 6, 'publisher': 'American Medical Association (AMA)', 'issue': '4', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 4, 1]]}, 'DOI': '10.1001/jamaoto.2020.5490', 'type': 'journal-article', 'created': {'date-parts': [[2021, 2, 6]], 'date-time': '2021-02-06T02:55:47Z', 'timestamp': 1612580147000}, 'page': '400', 'source': 'Crossref', 'is-referenced-by-count': 63, 'title': 'Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in ' 'Patients With COVID-19', 'prefix': '10.1001', 'volume': '147', 'author': [ { 'given': 'Jeremy', 'family': 'Guenezan', 'sequence': 'first', 'affiliation': [ { 'name': 'Emergency Department, University Hospital of Poitiers, Poitiers, ' 'France'}]}, { 'given': 'Magali', 'family': 'Garcia', 'sequence': 'additional', 'affiliation': [ { 'name': 'Virology laboratory, University Hospital of Poitiers, Poitiers, ' 'France'}]}, { 'given': 'Deidre', 'family': 'Strasters', 'sequence': 'additional', 'affiliation': [ { 'name': 'Emergency Department, University Hospital of Poitiers, Poitiers, ' 'France'}]}, { 'given': 'Clément', 'family': 'Jousselin', 'sequence': 'additional', 'affiliation': [ { 'name': 'Virology laboratory, University Hospital of Poitiers, Poitiers, ' 'France'}]}, { 'given': 'Nicolas', 'family': 'Lévêque', 'sequence': 'additional', 'affiliation': [ { 'name': 'Virology laboratory, University Hospital of Poitiers, Poitiers, ' 'France'}]}, { 'given': 'Denis', 'family': 'Frasca', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Anesthesia, Intensive Care and Perioperative ' 'Medicine, University Hospital of Poitiers, Poitiers, France'}]}, { 'given': 'Olivier', 'family': 'Mimoz', 'sequence': 'additional', 'affiliation': [ { 'name': 'Emergency Department, University Hospital of Poitiers, Poitiers, ' 'France'}]}], 'member': '10', 'reference': [ { 'issue': '8', 'key': 'old200020r1', 'doi-asserted-by': 'publisher', 'first-page': '782', 'DOI': '10.1001/jama.2020.12839', 'article-title': 'Pathophysiology, transmission, diagnosis, and treatment of coronavirus ' 'disease 2019 (COVID-19): A Review.', 'volume': '324', 'author': 'Wiersinga', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '11', 'key': 'old200020r2', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1001/jamaoto.2020.3053', 'article-title': 'In vitro efficacy of a povidone-iodine nasal antiseptic for rapid ' 'inactivation of SARS-CoV-2.', 'volume': '146', 'author': 'Frank', 'year': '2020', 'journal-title': 'JAMA Otolaryngol Head Neck Surg'}, { 'issue': '6', 'key': 'old200020r3', 'doi-asserted-by': 'publisher', 'first-page': '1871', 'DOI': '10.3390/jcm9061871', 'article-title': 'Performance assessment of SARS-CoV-2 PCR assays developed by WHO ' 'referral laboratories.', 'volume': '9', 'author': 'Etievant', 'year': '2020', 'journal-title': 'J Clin Med'}, { 'key': 'old200020r4', 'doi-asserted-by': 'publisher', 'first-page': '480', 'DOI': '10.1007/BF01863914', 'article-title': 'Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche.', 'volume': '162', 'author': 'Kärber', 'year': '1934', 'journal-title': 'Archiv f experiment Pathol u Pharmakol'}, { 'issue': '9', 'key': 'old200020r5', 'doi-asserted-by': 'publisher', 'first-page': '787', 'DOI': '10.1001/jamaoto.2020.1622', 'article-title': 'Benefits and safety of nasal saline irrigations in a pandemic—washing ' 'COVID-19 away.', 'volume': '146', 'author': 'Farrell', 'year': '2020', 'journal-title': 'JAMA Otolaryngol Head Neck Surg'}, { 'issue': '11', 'key': 'old200020r6', 'doi-asserted-by': 'crossref', 'first-page': '1571', 'DOI': '10.1016/S0002-8223(21)01843-5', 'article-title': 'A review of iodine toxicity reports.', 'volume': '90', 'author': 'Pennington', 'year': '1990', 'journal-title': 'J Am Diet Assoc'}], 'container-title': 'JAMA Otolaryngology–Head &amp; Neck Surgery', 'original-title': [], 'language': 'en', 'link': [ { 'URL': '', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 12, 15]], 'date-time': '2022-12-15T02:50:46Z', 'timestamp': 1671072646000}, 'score': 1, 'resource': {'primary': {'URL': ''}}, 'subtitle': ['A Randomized Clinical Trial'], 'short-title': [], 'issued': {'date-parts': [[2021, 4, 1]]}, 'references-count': 6, 'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2021, 4, 1]]}}, 'URL': '', 'relation': {}, 'ISSN': ['2168-6181'], 'subject': ['Otorhinolaryngology', 'Surgery'], 'container-title-short': 'JAMA Otolaryngol Head Neck Surg', 'published': {'date-parts': [[2021, 4, 1]]}}
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop